Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 009217
Company: MEDPOINTE PHARM HLC
Company: MEDPOINTE PHARM HLC
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
UNITENSEN | CRYPTENAMINE TANNATES | 260CSR UNIT | TABLET;ORAL | Discontinued | None | No | No |